Announcements Trials
Browse Landscape

Phase

Phase 2 42Phase NA 31Phase 3 19Phase EARLY_PHASE1 7Phase 4 7Phase 1 6Phase 2/3 5Phase 1/2 4

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3CNS 1

Conditions

Breast Neoplasms 2Glioblastoma 1Carcinoma, Intraductal, Noninfiltrating 1Biomarker Change Linked to Breast Cancer 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Cholecalciferol × Clear all
NCT02856503 2026-04-17

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

University of Miami

Phase 1/2 Withdrawn
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01425476 2017-08-09

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
45 enrolled
Breast

Breast Neoplasms

NCT01769625 2017-08-09

Changes in Biomarkers Using Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
31 enrolled
Breast

Biomarker Change Linked to Breast Cancer

NCT01181193 2011-03-29

Vitamin D for Treatment of Glioblastoma Multiforme

Soroka University Medical Center

Phase 1/2 Unknown
20 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡